November 27th 2024
A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.
Minimal recovery in HPV vaccination reported in Japan despite recommendations
July 17th 2024HPV vaccination coverage in Japan remains critically low despite the resumption of proactive recommendations by the Ministry of Health, Labour, and Welfare, highlighting the need for stronger cervical cancer control measures.
Read More
Fertility-sparing surgery matches standard surgery in cervical cancer survival
June 27th 2024A recent study reveals that fertility-sparing surgery offers similar survival outcomes to standard surgery for cervical cancer patients with tumors of 4 cm or smaller, potentially expanding treatment options for younger women.
Read More
HPV-16 identified as highest risk for CIN2 progression in women under active surveillance
June 24th 2024A recent study found that women with human papillomavirus -16 undergoing surveillance for cervical intraepithelial neoplasia grade 2 are at the highest risk of progression to more severe cervical lesions.
Read More
Guidelines released to boost cervical cancer screening in high-income countries
June 12th 2024The ACCESS Consensus Group's new guidelines aim to enhance cervical cancer screening and reduce mortality rates in high-income countries, emphasizing the urgent need for increased participation and innovative approaches such as self-sampling.
Read More
Impact of primary care physicians on cervical cancer screening disparities
May 14th 2024A study highlights how having a primary care physician significantly increases the likelihood of cervical cancer screening among lesbian, gay, and bisexual cisgender women, addressing disparities exacerbated by systemic discrimination and healthcare access challenges.
Read More
Study finds reduced CIN3+ risk from early HPV vaccination
April 16th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
Read More
Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening
February 21st 2024A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More
Protecting HIV-positive adolescents against high-risk HPV types
February 5th 2024A recent study found that the Gardasil quadrivalent HPV vaccine effectively shields HIV-positive adolescents from high-risk HPV types 16, 18, 6, and 11, shedding light on the potential for HPV vaccination to mitigate cancer risks in this vulnerable population.
Read More
FDA clears Genius Digital Diagnostics System for cervical cancer screening
February 2nd 2024Hologic's Genius Digital Diagnostics System, the first FDA-cleared digital cytology system using AI and advanced imaging, promises improved sensitivity in detecting pre-cancerous lesions and cervical cancer cells.
Read More
Two-dose HPV vaccination postpartum shows efficacy
January 30th 2024A recent study revealed a 2-dose regimen of human papillomavirus vaccination in postpartum individuals is as effective as a 3-dose approach, providing valuable insights into optimizing vaccination strategies against the virus.
Read More
Study explores link of social media health videos to HPV awareness
January 18th 2024A recent study found that watching health-related videos on social media significantly increases awareness about human papillomavirus (HPV) and the HPV vaccine, with data showing geographic variations and demographic influences on viewership and awareness levels.
Read More
Long-term HPV vaccine efficacy: 10-year study reveals protection in youth
January 4th 2024A decade-long study confirms significant protection against human papillomavirus remains in patients vaccinated up to age 20, reinforcing the World Health Organization's single-dose vaccination recommendation for adolescents.
Read More
Evaluating efficacy of active surveillance for CIN2
December 13th 2023Discover how active surveillance, a growing approach in managing cervical intraepithelial neoplasia, offers a nuanced alternative to immediate interventions, showcasing promising regression rates and reduced risk of overtreatment.
Read More
A study reveals how personalized digital health tools, such as a Digital Personal Health Librarian, leveraging electronic health records, social data, and advanced technologies, can not only enhance wellness care and preventive health but also significantly improve the uptake of interventions like HPV vaccination.
Read More